IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,052,360 | +80.2% | 55,475 | +47.3% | 0.01% | +50.0% |
| Q1 2023 | $584,137 | -67.7% | 37,662 | -63.0% | 0.01% | -60.0% |
| Q4 2022 | $1,806,684 | +175.4% | 101,785 | -13.3% | 0.02% | +200.0% |
| Q3 2022 | $656,000 | +209.4% | 117,424 | +381.2% | 0.01% | +150.0% |
| Q3 2021 | $212,000 | -59.9% | 24,400 | -51.2% | 0.00% | -66.7% |
| Q2 2021 | $529,000 | -40.4% | 50,000 | -9.6% | 0.01% | -45.5% |
| Q1 2021 | $887,000 | +3.1% | 55,303 | +196.9% | 0.01% | -8.3% |
| Q4 2020 | $860,000 | -45.6% | 18,629 | -58.5% | 0.01% | -60.0% |
| Q3 2020 | $1,581,000 | -5.6% | 44,912 | -34.7% | 0.03% | +36.4% |
| Q2 2020 | $1,674,000 | +24.1% | 68,800 | -19.1% | 0.02% | -33.3% |
| Q4 2019 | $1,349,000 | – | 85,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |